Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Gilead CSO McHutchison, two others, out as O’Day reshapes his team

July 17, 2019 7:17 PM UTC

With the departures of CSO John McHutchison, Chief Patient Officer Gregg Alton and EVP of Human Resources Katie Watson announced Wednesday, Daniel O'Day will be left with less than half of the 10-person senior management team he inherited when he took over as Gilead’s CEO in March.

McHutchison will step down next month after less than a year and a half as CSO and head of R&D. Gilead Sciences Inc. (NASDAQ:GILD) is searching for a successor...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Gilead Sciences Inc.